Valuation: Adocia

Market Cap 60.58M 67.64M 55.73M 50.49M 94.38M 6.42B 96.15M 665M 267M 3.38B 254M 248M 10.65B P/E 2026 *
5.97x
P/E 2027 * 4.77x
Enterprise Value 9.62M 10.74M 8.85M 8.02M 14.98M 1.02B 15.26M 105M 42.35M 536M 40.3M 39.44M 1.69B EV / Sales 2026 *
0.34x
EV / Sales 2027 * 2.33x
Free-Float
94.55%
Yield 2026 *
-
Yield 2027 * -
1 day-1.05%
1 week+26.27%
1 month+22.59%
3 months-23.54%
6 months-37.95%
Current year-54.81%
1 week 2.32
Extreme 2.318
3.45
1 month 2.01
Extreme 2.01
3.45
Current year 2.01
Extreme 2.01
7.45
1 year 2.01
Extreme 2.01
9.65
3 years 2.01
Extreme 2.01
12.66
5 years 2.01
Extreme 2.01
16.16
10 years 2.01
Extreme 2.01
61.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 57 -
Director/Board Member 61 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/25 Buy

Founder

109,170 0.6972%
4/6/24 Buy

Founder

15,576 0.1105%
4/6/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%+26.27%-65.28%-64.33% 67.64M
-0.62%-1.87%+42.87%+64.15% 63.77B
+0.35%+3.20%+14.40%+81.76% 56.37B
+0.53%+1.96%+16.24%+103.35% 54.62B
-2.81%-4.31%+23.50%+47.83% 44.06B
-0.33%-1.93%+19.28%+98.80% 42.11B
+0.55%+2.31%+225.14%+866.21% 41B
+3.27%+47.96%+112.84%+96.58% 34.92B
+1.22%-1.44%+14.57%+46.95% 32.82B
+0.89%+20.55%-40.62%+349.24% 24.7B
Average +0.20%+9.41%+36.29%+169.06% 39.44B
Weighted average by Cap. +0.18%+5.45%+47.97%+176.63%

Financials

2026 *2027 *
Net sales 28.39M 31.7M 26.11M 23.66M 44.22M 3.01B 45.05M 311M 125M 1.58B 119M 116M 4.99B 37.6M 41.98M 34.58M 31.34M 58.58M 3.99B 59.67M 412M 166M 2.1B 158M 154M 6.61B
Net income 8.5M 9.49M 7.82M 7.08M 13.24M 901M 13.49M 93.21M 37.42M 474M 35.61M 34.85M 1.49B -43.88M -48.99M -40.36M -36.57M -68.36M -4.65B -69.64M -481M -193M -2.45B -184M -180M -7.72B
Net Debt -50.97M -56.91M -46.88M -42.48M -79.4M -5.4B -80.89M -559M -224M -2.84B -214M -209M -8.96B 26.84M 29.97M 24.69M 22.37M 41.82M 2.85B 42.6M 294M 118M 1.5B 112M 110M 4.72B
Projected Income Statement - Annual - Adocia
Logo Adocia
Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The Company has a broad portfolio of drug candidates based on four proprietary technology platforms : BioChaperone® for the stabilization and enhancement of peptide formulations and combinations, AdoXLongTM, a long-acting peptide platform, AdOral®, an oral peptide delivery technology, and AdoShell®, an immunoprotective biomaterial for cell transplantation, with an initial application in pancreatic cells transplantation.
Employees
80
Date Price Change Volume
26-10-30 €3.028 -1.05% 834,037
26-10-29 €3.060 -1.99% 627,281
26-10-28 €3.122 +15.03% 993,457
26-10-27 €2.714 +10.50% 313,953
26-10-26 €2.456 +2.42% 211,529
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Adocia
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.028EUR
Average target price
9.450EUR
Spread / Average Target
+212.09%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Adocia
  1. Stock Market
  2. Stocks
  3. ADOC Stock